A novel strategy by pharmacological reprogramming reverses endothelial senescence and improves vascular regeneration

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Katrin Kalies

University Hospital Halle (Saale), Halle (Germany)

6 More presentations in this session

Presentation thumbnail

MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration

Doctor H. Kojima (Kyoto, JP)

Abstract Slides Video

Presentation thumbnail

Cardiac organoids as regenerative therapy in a preclinical model of acute myocardial infarction-Corrected version

Mrs M. Kalil (Badalona, ES)

Abstract Slides Video

Presentation thumbnail

Systemic administration of hEPSC-derived Trophoblast stem cells for cardiac regeneration

Doctor S. Liao (Hong Kong, HK)

Abstract Slides

Presentation thumbnail

MicroRNA-762 inhibition enhances angiogenesis and vascular regeneration by targeting XAF1 and CMPK2

Miss L. Hehl (Halle, DE)

Abstract Slides Video

Presentation thumbnail

Magnetic nanovesicle-mediated mRNA delivery targets injured cardiac tissue and rescues ischemic injury with low immunogenicity

Ms D. Mun (Seoul, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Innovative strategies for cardiac and vascular regeneration

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Targeting miR-148a-3p to reverse endothelial senescence and improve vascular repair post-MI

Congress Presentation

The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence

Congress Presentation

MicroRNA-762 inhibition enhances angiogenesis and vascular regeneration by targeting XAF1 and CMPK2

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources